UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)
May 7, 2010

WATSON PHARMACEUTICALS, INC.

(Exact Name of Registrant as Specified in Its Charter)

Nevada		001-03305		95-3872914
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

311 Bonnie Circle Corona, California		92880
(Address of Principal Executive Offices)		(Zip Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 5.07		Submission of Matters to a Vote of Security Holders.

     On May 7, 2010, the Annual Meeting of the Stockholders of Watson Pharmaceuticals, Inc. (“the Company”) was held in Parsippany, NJ. The following directors were elected to the Company’s Board of Directors for a term of three years expiring at the Annual Meeting of Stockholders in 2013:

     

		For				Against				Abstain				Broker Non-Votes
Paul M. Bisaro			90,923,656				606,242				3,111,548				9,355,424
Christopher W. Bodine			91,944,566				574,887				2,121,993				9,355,424
Michel J. Feldman			86,308,424				2,094,404				6,238,618				9,355,424
Fred G. Weiss			72,703,042				1,243,396				20,695,008				9,355,424

     

     In addition to voting to elect the aforementioned directors, the Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2010. The results of the vote were as follows:

     

		For				Against				Abstain
Ratification of Appointment of PricewaterhouseCoopers LLP			101,281,586				2,608,720				106,564

     

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.